Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 1,529.6 | 1,490.0 | 1,424.7 | 1,332.8 | 1,037.1 |
| Revenue growth | 2.7% | 4.6% | 6.9% | 28.5% | |
| Cost of goods sold | 2,410.6 | 2,527.6 | 2,433.9 | 950.5 | 831.1 |
| Gross profit | -881.0 | -1,037.6 | -1,009.2 | 382.3 | 206.0 |
| Gross margin | -57.6% | -69.6% | -70.8% | 28.7% | 19.9% |
| Sales and marketing | 124.8 | 113.2 | 106.6 | 107.1 | 81.9 |
| EBIT | 177.2 | 96.4 | 80.9 | -113.7 | -96.7 |
| EBIT margin | 11.6% | 6.5% | 5.7% | -8.5% | -9.3% |
| Pre-tax income | 168.2 | 61.3 | 10.5 | -145.4 | -100.4 |
| Income taxes | -172.4 | 1.2 | 0.3 | 0.0 | 0.0 |
| Tax rate | | 1.9% | 3.0% | | |
| Net income | 340.5 | 52.0 | 3.9 | -145.4 | -100.4 |
| Net margin | 22.3% | 3.5% | 0.3% | -10.9% | -9.7% |
| |
| Diluted EPS | $7.66 | $6.96 | $2.39 | ($207.20) | ($143.09) |
| Shares outstanding (diluted) | 44.5 | 7.5 | 1.6 | 0.7 | 0.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|